COVID-19 Relapses, Lack Of Omicron Data Complicate Paxlovid Case In India

CHAI Hints At $25 A Course For Generic

Representation Of A Paxlovid Pill
The World's Eyes Are On Paxlovid As COVID-19 Cases Pick Up Again • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip